February 19, 2026
1 min read

Moderna’s mRNA Flu Vaccine Back Under FDA Review MedNews

THURSDAY, Feb. 19, 2026 In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna s experimental mRNA influenza vaccine. Th

Leave a Reply

Your email address will not be published.

Previous Story

Kefir and Fiber Combination Triggers Massive Reduction In Inflammation (Better Than Supplements)

Next Story

Industry, Consumer Groups Still at Odds over Broadband Nutrition Labels

Previous Story

Kefir and Fiber Combination Triggers Massive Reduction In Inflammation (Better Than Supplements)

Next Story

Industry, Consumer Groups Still at Odds over Broadband Nutrition Labels

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader

STAT+: A new attack on AMA’s billing codes

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Brain
Go toTop